Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2026-01-03 @ 11:36 AM
Study NCT ID:
NCT04159493
Status:
WITHDRAWN
Last Update Posted:
2021-07-23
First Post:
2019-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy
Sponsor:
Aspen USA Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-05-15
Completion Date Type:
ESTIMATED
First Submit Date:
2019-10-22
First Submit QC Date:
None
Study First Post Date:
2019-11-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-19
Last Update Post Date:
2021-07-23
Last Update Post Date Type:
ACTUAL